Conor K Farren. St Patricks University Hospital Trinity College Dublin Ireland

Similar documents
The contribution of applied psychologists to recovery oriented substance misuse treatment systems

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION

NICE Clinical Guidelines recommending Family and Couple Therapy

Alcohol Interventions: NICE guidelines and beyond. Professor Colin Drummond

Clinical guideline Published: 23 February 2011 nice.org.uk/guidance/cg115

IDDT Fidelity Action Planning Guidelines

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Clarifying brief interventions

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Job Description hours (worked flexibly within the service opening hours)

Community alcohol detoxification in primary care

SFHPT02 Develop a formulation and treatment plan with the client in cognitive and behavioural therapy

Models of good practice in drug treatment in Europe. Project group

MANAGEMENT OF DUAL DIAGNOSIS

Revised Standards. S 1a: The service routinely collects data on age, gender and ethnicity for each person referred for psychological therapy.

Disclosure statement

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Comorbidity Guidelines Training Program

Drug Misuse and Dependence Guidelines on Clinical Management

Substance use and misuse

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

ROYAL COLLEGE OF PSYCHIATRISTS RAPID EVIDENCE REVIEW OF EVIDENCE-BASED TREATMENT FOR GAMBLING DISORDER IN BRITAIN

WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS

Integrating ITEP BETI across services

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Common mental health disorders

Anxiety Disorders: First aid and when to refer on

Alcohol treatment: improving services after the reforms?

Guidelines for the vetting of warrant applications (core competencies)

The Woodlands Managing Alcohol To Support Recovery In Mental Health

Treatment Alternatives for Substance Use Disorders

Depression & Alcohol

CommunIty detox. InformatIon LeafLet

Position is based Access Health & Community: Hawthorn and Doncaster East Manager, Alcohol and Other Drug Service

Psychosis with coexisting substance misuse

Updated Activity Work Plan : Drug and Alcohol Treatment. Western NSW PHN

SFHAI1 Use recognised theoretical models to provide therapeutic support to individuals who misuse substances

Depression in children: identification and management of depression in children and young people in primary, community and secondary care

Updated Activity Work Plan : Drug and Alcohol Treatment NEPEAN BLUE MOUNTAINS PHN

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE

Update from NIAAA. Alcohol Prevention, Treatment, and Recovery Research

depression in England: CLAHRC findings on current performance &

Medication-Assisted Treatment. What Is It and Why Do We Use It?

South Tees Hospitals NHS Foundation Trust. Excellence in dementia care across general hospital and community settings. Competency framework

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people

Prescribing Framework for Naltrexone in Alcohol Relapse Prevention

Primary Health Networks

Improving Access to Psychological Therapies. Guidance for faith and community groups

Clinical guideline Published: 25 May 2011 nice.org.uk/guidance/cg123

Psychological and Psychosocial Treatments in the Treatment of Borderline Personality Disorder

HA Corporate Scholarship Program:

Surveillance report Published: 8 June 2017 nice.org.uk. NICE All rights reserved.

Integrated Dual Disorder Treatment IDDT

Technology appraisal guidance Published: 26 November 2014 nice.org.uk/guidance/ta325

Smoking cessation interventions and services

If gambling treatment was evidence based, what would it look like?

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

For Multiply Excluded Homeless People. Introduction

For Multiply Excluded Homeless People. Slide Design by Paul Ashton

Clinical guideline Published: 23 March 2011 nice.org.uk/guidance/cg120

BNSSG Shared Care Guidance Please complete all sections

Responding Effectively to BPD Challenges for the Service System. Katerina Volny Peter McKenzie

Clinical Guidelines and Procedures for the Use of Naltrexone in the Management of Opioid Dependence Abbreviated Version

Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging.

SCDSW17 Apply methods and models of social work intervention to promote change

Resource impact report: Eating disorders: recognition and treatment (NG69)

Who is it for? About Cognitive-Behaviour Therapy

A MULTI-LAYERED APPROACH TO RECOVERY: VETERAN AND MILITARY FAMILY CASE EXAMPLES

Substance Misuse in Older People

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme

Treatment Approaches for Drug Addiction

C AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS

Recommendation 2: Voluntary groups should be supported to build their capacity to promote mental health among their client groups.

CAMHS. Your guide to Child and Adolescent Mental Health Services

Aquarius An Overview

Depression in adults: treatment and management

An Internist s Guide to Unhealthy Alcohol Use. Ryan Graddy, MD JHU SOM

TITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness

Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care

Trigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS

Biopsychosocial Model. A Theory of Addiction

Mental Health and AoD Community Briefing Outcomes

Mental Health & Wellbeing Strategy

Adult 65D-30 Intervention ASAM Level.05 DIMENSIONS Circle all items in each dimension that apply to the client. ADMISSION CRITERIA

The science of the mind: investigating mental health Treating addiction

Document Title Pharmacological Management of Generalised Anxiety Disorder

Putting NICE guidance into practice. Resource impact report: Post-traumatic stress disorder (NG116)

ROSC & MAT II: Opioid Treatment Services

JOB DESCRIPTION. Job Title: Part time (0.7) Clinical Psychologist - Band 7 Equivalent

10 INDEX Acknowledgements, i

02/GMS/0030 ADULT EPILEPSY SERVICE CCP for General Medical and Surgical POOLE HOSPITAL NHS FOUNDATION TRUST

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS

Recommendations from the Devon Prisons Health Needs Assessment. HMP Exeter, HMP Channings Wood and HMP Dartmoor

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

Clinical guideline Published: 28 October 2009 nice.org.uk/guidance/cg90

What recovery means: Independent living. Control of symptoms. Active remission of substance use. Competitive employment

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

SFHPT05 Foster and maintain a therapeutic alliance in cognitive and behavioural therapy

APS Submission to the MBS Review: Better Access to Psychiatrists, Psychologists and General Practitioners

Transcription:

Conor K Farren St Patricks University Hospital Trinity College Dublin Ireland

NICE: Background NICE set up in 1999 to reduce variation in availability and quality of NHS treatments. Does this by: Evidence based guidance for health care workers. Quality standards for those providing and commissioning health care services Provides information for practitioners Clinical guidelines provide advice on individual patient management: Systematically developed statements to assist professional decisions.

AUD Guidelines: Background Developed by panel of experts, lay members, service users and guideline experts Based upon best- available research Attempts to evaluate the research to translate it into recommendations Where evidence is lacking, develop consensus statements and recommendations.

Transla:on into Clinical Prac:ce Guidelines only released in 2011. Thus no research on whether it has been adopted. Only one study examining NICE compliance, regarding alcohol screening, suggesting practice is in line with guidelines.

Interven:on Principles Assessment: Motivational Interview Help people recognise their problems Help resolve ambivalence, encourage positive change Takes a persuasive and not a confrontational position. Offer community based intervention if MI is not successful. If homeless, residential setting for 3 months All staff should be appropriately trained, supervised and monitored. All clinical outcomes should be measured. All subjects should be encouraged to self- help groups and community support.

Abs:nence versus Harm Reduc:on For patients with alcohol dependence: abstinence is preferred outcome For those with alcohol dependence who don t want to abstain, harm reduction is appropriate goal, with advice about preference of abstinence. For mild dependence/harmful drinking, harm reduction can be an appropriate goal, if that is what the patient wants. Abstinence can also be the target in this population.

Interven:ons acer Withdrawal: Pharmacotherapy Consider oral naltrexone or acamprosate in combination with individual psychological therapy Or combined with couples therapy. Consider disulfiram as alternative, if patient prefers. Conduce baseline medical assessment inc liver function tests. If using acamprosate: 6 weeks only if keeps drinking. If using naltrexone: 6 weeks only if keeps drinking.

Acamprosate Based upon analysis of 19 published clinical trials Evidence considered strong Usual dose 666mg x3/day for up to 6 months or longer if patient is benefitting Routine blood tests not required but may help monitor liver function recovery Little evidence of benefit for harmful / mild dependence

Oral naltrexone Based upon 27 published clinical trials. Recommended for relapse prevention in moderate to severe dependence, with psychological intervention. Begin prescribing at 25mg/day and aim for 50mg/day. Prescribe for up to 6months or longer if benefitting. Routine blood tests not required but consider these for older/obese patients - may help monitor liver function recovery. Also recommended at 50mg/day dose for less severe / non- dependence. Injectable naltrexone: Evidence is limited and inconclusive, not recommended in routine clinical

Combina:on naltrexone/ acamprosate Based upon 4 published clinical trials Evidence considered moderate Some evidence for the combination of naltrexone and acamprosate together in some outcome variables only For higher dependency alcoholics only

Disulfiram Evidence was considered moderate, not high. Prescribed at dose of 200mg per day, can be increased Thorough medical assessment Patient should be under supervision for 6 months Family member or carer should help administration Full warning regarding: Interaction with alcohol Rare onset of hepatotoxicity

An:- depressants Little to no effect on depression symptoms for those who are non- abstinent Effect on alcohol use limited: abstinence not sustained Severe depression improved by antidepressants, but alcohol- focussed treatment still needed. Little evidence that one antidepressant is better than another

Interven:ons acer Withdrawal: Psychotherapy Strongest evidence for behavioural couples therapy Advantage over treatment as usual, active controls and other active interventions Recommended as an effective stand- alone intervention for harmful / mild dependence where a partner is willing to engage 1x60min session per week for 12 weeks

Recommended therapies Limited but strong evidence of superiority over treatment as usual / controls for Individual CBT and behavioural therapy (1 x 60min session per week for 12 weeks) Social network / environment- based therapy (8 x 50min sessions over 12 weeks)

Other therapies No evidence of superiority over other interventions / treatment as usual / control for... Twelve step facilitation Motivational techniques BUT These techniques are useful as a component of psychosocial interventions Community support (e.g. AA) is a key element of care coordination

Other therapies Inconclusive evidence for... Contingency management Limited, low- quality evidence for... Counselling Short- term psychodynamic therapy Multi- modal treatment Self- help- based treatment Psychoeducational interventions Mindfulness meditation

Dual diagnosis Co- morbid Depression / anxiety Antidepressants have not been shown to reduce alcohol misuse alone Limited use of benzodiazepines may be continued to manage anxiety Anxiety symptoms may persist 6-8 weeks into abstinence Recommendation: Address alcohol misuse first, Assess for ongoing mood symptoms 3-4 weeks into abstinence Treat symptoms if they have not abated

Alcohol and depression Some evidence that sertraline and naltrexone is better than either alone Mixed evidence regarding CBT Outcomes improve when one weeks abstinence is allowed before diagnosis Treat alcohol misuse first, assess for depressive symptoms after 3-4 weeks, and then treat.

Société Française d Alcoologie (1999) Highlighted the need for diversified and coherent organisation Access, competency in personnel, increased manpower, social support, outpatient clinics, evaluation of provisions for care Recommend regrouping of services into specialised alcohol networks. General guidelines Patient should be informed of possibilities of follow- up and care Need to facilitate setting up a network of supports and interventions in line with the patient's wishes Need to use validated tools to set up social support Need to monitor efficacy and tolerance of medications, and keep abreast of new therapies

Société Française d Alcoologie (1999) Psychosocial interventions Like NICE, strongest recommendations for CBT and couples therapy Highlighted value of family therapies and mutual aid groups Pharmacological intervention Disulfiram call for further research at the time, potential for harm Cautioned use of benzodiazepines limit their use during detox, no evidence for effectiveness in reducing drinking No comment at the time on acamprosate or naltrexone

NICE guidelines revisions A formal review of the need to update a guideline is usually undertaken by NICE 3 years after its publication. At this time it may be updated partially or in its entirety, or no update may be deemed necessary. New evidence may be incorporated before the 3year point where there is a concern about patient safety or significant alteration in practice.

Advantages of NICE Guidelines Clear and precise Based upon clinical evidence, thorough and exhaustive Only use expert recommendation if evidence lacking Used in addition to other NICE guidelines in psychiatry and general medicine. Published in English, widely accessible, makes the guidelines more easily translatable to other countries. Updated regularly.